Dr. Patt on Impact of Healthcare Reform Changes on Oncology Care

Debra Patt, MD
Published: Monday, Sep 21, 2015



Debra Patt, MD, physician, Texas Oncology, discusses the current healthcare reform changes and what effects they will have on oncology care.

Because of age distribution and population changes, there will also be several changes in the field of oncology, Patt says. The number of individuals over the age of 65 is expected to double in the next 20 years, based on predictions by the US Census Bureau. Asmore than half of cancers occur in patients 65 and older, the cancer population will likely substantially increase, Patt adds.

This also means that more patients are surviving cancer, as well as are on chronic treatments for their disease. For patients receiving long-term treatment, this poses unique workforce demands on oncologists and access to care conflicts. This is significant, she says, because patients with cancer often need access to several, more expensive treatments.



Debra Patt, MD, physician, Texas Oncology, discusses the current healthcare reform changes and what effects they will have on oncology care.

Because of age distribution and population changes, there will also be several changes in the field of oncology, Patt says. The number of individuals over the age of 65 is expected to double in the next 20 years, based on predictions by the US Census Bureau. Asmore than half of cancers occur in patients 65 and older, the cancer population will likely substantially increase, Patt adds.

This also means that more patients are surviving cancer, as well as are on chronic treatments for their disease. For patients receiving long-term treatment, this poses unique workforce demands on oncologists and access to care conflicts. This is significant, she says, because patients with cancer often need access to several, more expensive treatments.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x